Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03787615 · ClinicalTrials.gov registry record · NA
Feasibility of Using sipIT Tools to Increase Compliance With Fluid Consumption Guidelines in Urolithiasis-Prone Subjects
A NA study of Urolithiasis, sponsored by Penn State University.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
- 1
- Study location
NCT03787615: Completed NA study of Urolithiasis, sponsored by Penn State University.
NCT03787615 is a NA study of Urolithiasis that has completed, run by Penn State University. The registered enrollment target is 31 participants, below the 378-participant average among 11 other Urolithiasis trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03787615, a NA study of Urolithiasis, has completed, sponsored by Penn State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine the feasibility of using sipIT tools (i.e., wrist-worn sensors, smart water bottles, mobile applications) to increase compliance with physician-recommended fluid consumption guidelines in participants with a history of urolithiasis. The study aims to: 1) deliver notifications regarding fluid consumption to the FitBit Versa and the participant's smartphone based on the participant's assessed fluid intake, and 2) determine the acceptability of using the sipIT tools to increase fluid consumption. It is hypothesized that receiving notifications regarding fluid consumption will lead to an increased compliance in attaining fluid consumption guidelines. Further, it is hypothesized that the frequency of notifications will diminish across the study duration.
Primary Outcome
Participants who continue to use the sipIT tools (app, connected water bottle, and smartwatch) at 3 month follow-up
Conditions Studied
Interventions
- DEVICE sipIT tools
Study Locations (1)
Pennsylvania
- The Pennsylvania State University - University Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2018-11-19 |
| Est. Completion | 2019-12-01 |
| Phase | NA |
What the finished NCT03787615 record still lists
NCT03787615 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 378-participant average among 11 other Urolithiasis trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Urolithiasis appearing as the primary indexed condition, and to 1 intervention - of which sipIT tools is the first listed.
NCT03787615 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03787615 about?
NCT03787615 is a clinical study titled "Feasibility of Using sipIT Tools to Increase Compliance With Fluid Consumption Guidelines in Urolithiasis-Prone Subjects". The purpose of this study is to examine the feasibility of using sipIT tools (i.e., wrist-worn sensors, smart water bottles, mobile applications) to increase compliance with physician-recommended fluid consumption guidelines in participants with a history of urolithiasis. The study aims to: 1) deliv...
What is the current status of trial NCT03787615?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2018-11-19. Estimated completion is 2019-12-01.
What conditions does trial NCT03787615 study?
This clinical trial studies the following conditions: Urolithiasis.
What interventions are being tested in trial NCT03787615?
The interventions under investigation include: sipIT tools (DEVICE).
Who is sponsoring clinical trial NCT03787615?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03787615 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urolithiasis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03787615's enrollment target sits among peer trials
31 10th of 11 higher than 2 of 11 other Urolithiasis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Urolithiasis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease
RECRUITING · NA
-
Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure
RECRUITING · NA
-
Gut Oxalate Absorption in Calcium Oxalate Stone Disease
RECRUITING · NA
-
O. Formigenes Colonization in Calcium Oxalate Kidney Stone Disease
RECRUITING · NA
-
Ultrasound Imaging of Kidney Stones and Lithotripsy
ACTIVE NOT RECRUITING · NA
-
SOUND Pivotal Trial - (Sonomotion stOne comminUtion resoNance ultrasounD)
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI